Herpes Zoster (Shingles) - Pipeline Review, H2 2012 New Report
Herpes Zoster (Shingles) - Pipeline Review, H2 2012, provides an overview of the Herpes Zoster (Shingles) therapeutic pipeline. This report provides information on the therapeutic development for Herpes Zoster (Shingles), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Herpes Zoster (Shingles). 'Herpes Zoster (Shingles) - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC...
View full press release